• Brent Saunders
    Brent Saunders
    Chairman

    Brent Saunders

    Chairman

    Brent has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. Until May 2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63 billion, Brent served as Chairman, President and Chief Executive Officer of Allergan plc. His role as President and Chief Executive Officer of Allergan began in July 2014 and his added role of Chairman began in October 2016. Brent’s first role as an executive officer in the pharmaceuticals and healthcare sectors began in 2003, as a member of the executive management team at Schering-Plough Corporation, where he held several key roles, including President of the company’s Global Consumer Health Care division. While at Schering-Plough, Brent led the integrations of the company’s $14 billion acquisition of Organon Biosciences N.V in 2007 as well as the merger between Schering-Plough and Merck & Co., Inc. in 2009. From March 2010 until August 2013, Brent served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, until its acquisition by Valeant Pharmaceuticals, Inc. in 2013. He then became the Chief Executive Officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis plc in 2014. Following the merger with Actavis, Brent was named Chief Executive Officer of the combined business. In 2015, he led Actavis’ acquisition of Allergan, renaming the combined company Allergan Plc.

    Before joining Schering-Plough in 2003, Brent was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care, Inc. and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Brent began his career as Chief Compliance Officer for the Thomas Jefferson University Health System.

    Brent currently serves as Chairman and CEO of Bausch + Lomb Corporation.

  • Marla Beck
    Marla Beck
    President and Chief Executive Officer

    Marla Beck

    President and Chief Executive Officer
    Marla is President and Chief Executive Officer of BeautyHealth and has served on the Company’s Board of Directors since June 2022.

    A serial entrepreneur and visionary brand-builder, Marla is the founder and former CEO of Bluemercury, the disruptive omnichannel beauty and spa retailer founded in 1999. Marla brings a track record of building enduring and authentic brands and delivering significant value. She led Bluemercury from inception to a strategic sale to Macy’s in 2015, and continued to lead the company as an independent business unit of Macy’s until 2021. Under Marla’s leadership, Bluemercury’s presence spanned nearly 200 brick and mortar stores, a thriving e-Commerce platform, a highly penetrated loyalty program, and private label product brands M-61 Powerful Skincare and Lune+Aster Cosmetics.

    Marla has been recognized for her exceptional entrepreneurial success and leadership in business; she was an Ernst and Young Entrepreneur of the Year National Finalist in 2015 and one of Goldman Sachs’ 100 Most Intriguing Entrepreneurs in 2014. Today, Marla is Chair of the Advisory Board of Harvard Business School’s Rock Center for Entrepreneurship and the Center for Public Leadership Advisory Board at Harvard’s Kennedy School of Government.

    Marla holds a Bachelor of Arts degree from University of California, Berkeley and Masters degrees in Business and Public Administration from Harvard University.
  • Capellas
    Michael Capellas

    Michael Capellas

    Michael is the founder and CEO of Capellas Partners, a strategic technology advisory firm.

    He currently serves on the Board of Flex (Chair), Cisco (Lead Independent Director), and Blue Yonder (Chair). He is a Senior Advisor to Blackstone.

    ​ A four-time corporate CEO, Michael’s career as a global technology leader has spanned from innovative technology start-ups to large corporate turnarounds. ​

    He spent the first decade of his career at Schlumberger, followed by positions at software leaders, Oracle and SAP. In 1999, Michael was named CEO of Compaq Computer Corporation and a year later, added the title of chairman. During his tenure, the company was recognized as the global leader in computer servers. He was named President of Hewlett Packard following the merger between Compaq and HP. ​

    In 2002, Michael was recruited as Chairman and CEO of Worldcom post- bankruptcy and transformed the company from a long distance provider into the world’s largest carrier of internet traffic. After the restructuring, WorldCom relisted on the NASDAQ as the new MCI. After Verizon acquired MCI, Michael was named Chairman and CEO of First Data Corporation, a global leader in payments and electronic commerce.

    ​ From 2009 through 2012, Michael became Founding Chairman and CEO of VCE, the Virtual Computing Company, a joint venture between Cisco, EMC and VMware which developed and commercialized an innovative platform for cloud computing. During his tenure at VCE, Michael co-chaired the Federal Commission on Deployment of the Cloud (Cloud2), comprised of 71 leading U.S. companies and universities, who finalized a set of recommendations for driving U.S. cloud adoption, spurring U.S. job growth and enhancing overall U.S. competitiveness in the world.

    ​ He graduated from Kent State University and lives in Atlanta, Georgia.
    Member of the Audit Committee
    Chair of the Nominating and Corporate Governance Committee
  • Stephen J. Fanning
    Stephen J. Fanning

    Stephen J. Fanning

    Stephen J. Fanning is a medical aesthetics veteran with extensive industry knowledge and proven success in driving global growth.

    Mr. Fanning brings decades of global medical aesthetics experience, including serving as Hydrafacial’s Chairman of the Board from 2016 to 2020, prior to the Company’s initial public offering. He was recently the President and Chief Executive Officer of Spectrum Solutions, a molecular diagnostics firm, and previously led Z-Medica, boosting sales and EBITDA before its acquisition by Linden Capital. Mr. Fanning also headed Solta Medical, known for Thermage and Fraxel, and held leadership roles at Ocular Sciences and Johnson & Johnson, driving international growth.

    He currently serves as Chairman of the Board for Champion Manufacturing and LKC Technologies.

    Mr. Fanning holds a Bachelor of Science degree from Philadelphia University.

    Member of the Nominating and Corporate Governance Committee
    Member of the Audit Committee
  • Desiree Gruber
    Desiree Gruber

    Desiree Gruber

    Peabody Award-winner Desiree Gruber founded Full Picture, a brand accelerator, content production, communications, and consulting services company now in its 21st year, with a passion to help her clients more effectively tell their stories and launch new ideas into the world. Gruber continues to evolve her mission of shaping zeitgeist-defining moments and reimagining how brands delight and engage global audiences in her work as an entrepreneur, business strategist, and venture capitalist.

    Through Diagonal Ventures (DGNL), Gruber has embraced a preeminent role in developing and supporting female founders and C-suite executives. With a goal of creating real opportunities for women to achieve measurable success, DGNL invests in and architects transformational deals across the consumer, technology, and media spectrum in order to establish a legacy of female empowerment.

    Among Gruber’s many accomplishments to date is co-founding the Project Runway television series. In addition to her Peabody Award, as executive producer of the groundbreaking show for 16 seasons she received a GLAAD Media Award and earned 14 Emmy nominations.

    A lifelong advocate for a more equitable and inclusive world, she proudly serves on the boards of UNICEF USA, Tech:NYC, and God's Love We Deliver, and was the recipient of UNICEF’s 2018 Spirit of Compassion Award. She is also an advisor to leading organizations such as Anthos Capital, Pharrell Williams’ Something in the Water, and Chegg.

    Gruber lives with her husband, Kyle MacLachlan, and their son.

    Member of the Compensation Committee
  • Kerrick
    Michelle C. Kerrick

    Michelle C. Kerrick

    Michelle Kerrick is an accomplished leader and retired “Big 4” accounting firm partner with 35 years of diverse management and executive leadership experience, with Deloitte. She currently serves on the boards of the publicly traded REIT, American Homes 4 Rent (NYSE: AMH), Beauty Health (SKIN) and SoftBank’s LDH Growth Corp I (LDHAU).

    Michelle has been a trusted advisor to Fortune 500 C-suite executives, corporate boards and audit committees across a broad set of industries including real estate/REITs, consumer products and technology. She brings experience in the areas of financial and strategic planning, operational effectiveness and digital transformation. She also has a strong background in corporate governance and is qualified to serve as a financial expert.

    Michelle served as the West Region Market Leader and Managing Partner of the Los Angeles office of Deloitte, the world’s largest professional services firm. As one of three regional leaders in the U.S., Michelle helped drive national strategy, client and business growth, and strategic positioning across the region, which included 13 offices in eight states, and over 9,000 people. Under her leadership the region grew to over $3 billion in annual revenues and was consistently the fastest growing region in the U.S. Firm. As the leader of the Los Angeles practice, which employed more than 2,200 audit, tax, consulting, and financial advisory services professionals, the practice grew by more than 50% and attained revenues in excess of $450 million.

    Michelle began her career with Deloitte in the Phoenix office in the Audit group in 1985. She became a Partner of the Firm in 1998 and Managing Partner of the Phoenix Office in 2005. She transferred to Los Angeles as the Managing Partner in late 2010 and became the West Region Market Leader in 2019. Michelle advised a diverse group of public and privately held companies ranging from middle market to large multi-nationals and now serves as a board member to public and private/pre-IPO companies.

    As a relationship leader and financial expert, Michelle led the Firm’s National CFO Leadership Program for the West Region which focused on supporting CFOs in their complex roles. Michelle led the relationships with strategic Deloitte client’s including Mattel, the Los Angeles Sports and Entertainment District (Sofi Stadium), CBRE and Snap Inc. During her career she gained extensive experience in the board room working with the Audit Committees and Boards of companies including Mattel, Teledyne, Taylor Morrison, Kilroy Realty and TCW Group on a range of complex issues, including digital transformation, IPOs, cost reduction, cybersecurity, governance and enterprise risk.

    Michelle has deep experience in governance roles within Deloitte. She served on Deloitte’s Board Council and Strategic Investment Committee in which she oversaw various acquisitions and investments. Michelle also served two terms on Deloitte’s Nominating Committee which is responsible for CEO and board director selection.

    As a community leader, Michelle held a number of senior governance roles in prominent professional and community organizations. She served as the 2018 Board Chair of the Los Angeles Chamber of Commerce; board member of Los Angeles Sports and Entertainment Commission; Board of Advisors for Salvation Army Western Territories; a member Young President’s Organization Los Angeles Gold; and a Director of Polytechnic School in Pasadena. She was also on the Bid Committees which secured the 2022 Super Bowl, as well as the 2028 Olympic Summer Games for Los Angeles.

    She is committed to the advancement of women in the workplace. Michelle was named a Los Angeles Top 500 Leader, “Executive of the Year,” as well as, one of the “Most Influential Women in Accounting” by the Los Angeles Business Journal.

    Michelle received her B.S. degree in accountancy from Northern Arizona University and is a recipient of the University’s outstanding alumnus award. Michelle is a Retired member of the California and Arizona State Boards of Accountancy, and the American Institute of Certified Public Accountants.

    She and her daughter primarily reside in Phoenix, AZ with a part-time residence in McCall, ID.
    Chair of the Audit Committee
    Member of the Nominating and Corporate Governance Committee
  • Miller
    Brian Miller

    Brian Miller

    Brian Miller is a Managing Partner and Co-Founder of Linden Capital Partners. He has been involved in healthcare principal investing since 1998. Prior to Linden, Brian was a founding member of the healthcare team at First Chicago Equity Capital. Mr. Miller began his career in the investment banking division of Salomon Brothers Inc. (currently Citigroup). He is currently a board member of Beauty Health Co., MeriCal, Collagen Matrix, Vital Care, StatLab, and Formulated Solutions, and was previously a board member of Flexan, Z-Medica, Solara, SeraCare, BarrierSafe Solutions International, CORPAK MedSystems, HYCOR Biomedical, Strata Pathology Services and Suture Express.

    Mr. Miller holds a Bachelor of Arts with honors in Economics from Princeton University and an MBA from Harvard Business School, with a concentration in healthcare. He is a board member of AdvaMed, the Founder of the Healthcare Private Equity Association, the founder of Private Equity Analysts of Chicago, a Trustee of The University of Chicago Medical Center, and a member of the Economic Club of Chicago.

    Member of the Compensation Committee
    Member of the Nominating and Corporate Governance Committee
  • Doug
    Doug Schillinger

    Doug Schillinger

    Doug is a Managing Director with DW Healthcare Partners. His investment and transaction experience include bio-analytical/immune-analytical service laboratories, institutional and specialty pharmacies, medical device manufacturers in the cardiac and orthopedic markets, physician practice management companies, elder care service providers and clinical research organizations.

    Before joining DW Healthcare Partners, Doug worked for Bain & Company. While there, Doug led strategic due diligence efforts as part of Bain’s Private Equity Group. Prior to joining Bain’s Private Equity Group, Doug advised Bain’s commercial clients in the consumer products and food service industries.

    Doug also worked with Accenture (formerly Andersen Consulting), an international consulting firm focused on information technologies and process reengineering.

    Doug was raised in Connecticut. He has received a Bachelors degree from Cornell University and an MBA with Distinction from Harvard Business School, and currently sits on the Harvard Business School Alumni Board of Directors.
    Chair of the Compensation Committee
    Member of the Audit Committee